Purpose The purpose of this study was to evaluate in vivo the role of the micro-balloon by comparing trans-arterial chemoembolization (DEB-TACE) and selective internal radiotherapy (SIRT) procedures performed with and without balloon micro-catheter (b-DEB-TACE and DEBTACE/ SIRT and b-SIRT) for the treatment of hepatocellular carcinoma (HCC). Methods The impact of a balloon micro-catheter on transarterial loco-regional treatment was analyzed using nonenhanced post-procedural cone-beam CT (Ne-CBCT) by comparing the attenuation values in the embolized area and the surrounding liver tissue before and after DEB-TACEversus b-DEB-TACE and by comparing 2D/3D dosimetry in single-photon emission computed tomography after SIRT versus b-SIRT, and by comparing the histological count of the beads following orthotopic liver transplantation in the DEB-TACE versus b-DEB-TACE subgroup. Results We treated 84 HCC patients using trans-arterial loco-regional therapy. Fifty-three patients (26 DEB-TACE and 27 b-DEB-TACE) were analyzed in the TACE group. Contrast, signal-to-noise ratio, and contrast-to-noise ratio were all significantly higher in b-DEB-TACE subgroup than DEB-TACE (182.33 HU [CI95% 160.3–273.5] vs. 124 HU [CI95% 80.6–163.6]; 8.3 [CI95% 5.7–10.1] vs. 4.5 [CI95% 3.7–6.0]; 6.9 [CI95% 4.3–7.8] vs. 3.1 [CI95% 2.2–5.0] p.05). Thirty-one patients (24 SIRT and 7 b-SIRT) were analyzed in the SIRT group. 2D dosimetry profile evaluation showed an activity intensity peak significantly higher in the b-SIRT than in the SIRT subgroup (987.5 ± 393.8 vs. 567.7 ± 302.2, p = 0.005). Regarding 3D dose analysis, the mean dose administered to the treated lesions was significantly higher in the b-SIRT than in the SIRT group (151.6 Gy ± 53.2 vs. 100.1 Gy ± 43.4, p = 0.01). In histological explanted liver analysis, there was a trend for higher intra-tumoral localization of embolic microspheres for b-DEB-TACE in comparison with DEBTACE. Conclusions Due to the use of three different methods, the results of this study demonstrate in vivo, a better embolization profile of oncological intra-arterial interventions performed with balloon micro-catheter regardless of the embolic agent employed.
In vivo comparison of micro-balloon interventions (MBI) advantage: a retrospective cohort study of DEB-TACE versus b-TACE and of SIRT versus b-SIRT / Lucatelli, Pierleone; De Rubeis, Gianluca; Trobiani, Claudio; Ungania, Sara; Rocco, Bianca; De Gyurgyokai, Simone Zilahi; Masi, Marica; Pecorella, Irene; Cappelli, Federico; Lai, Quirino; Catalano, Carlo; Vallati, Giulio. - In: CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. - ISSN 0174-1551. - (2022). [10.1007/s00270-021-03035-5]
In vivo comparison of micro-balloon interventions (MBI) advantage: a retrospective cohort study of DEB-TACE versus b-TACE and of SIRT versus b-SIRT
Lucatelli, Pierleone
Primo
;De Rubeis, GianlucaSecondo
;Trobiani, Claudio;Rocco, Bianca;De Gyurgyokai, Simone Zilahi;Pecorella, Irene;Cappelli, Federico;Lai, Quirino;Catalano, CarloPenultimo
;
2022
Abstract
Purpose The purpose of this study was to evaluate in vivo the role of the micro-balloon by comparing trans-arterial chemoembolization (DEB-TACE) and selective internal radiotherapy (SIRT) procedures performed with and without balloon micro-catheter (b-DEB-TACE and DEBTACE/ SIRT and b-SIRT) for the treatment of hepatocellular carcinoma (HCC). Methods The impact of a balloon micro-catheter on transarterial loco-regional treatment was analyzed using nonenhanced post-procedural cone-beam CT (Ne-CBCT) by comparing the attenuation values in the embolized area and the surrounding liver tissue before and after DEB-TACEversus b-DEB-TACE and by comparing 2D/3D dosimetry in single-photon emission computed tomography after SIRT versus b-SIRT, and by comparing the histological count of the beads following orthotopic liver transplantation in the DEB-TACE versus b-DEB-TACE subgroup. Results We treated 84 HCC patients using trans-arterial loco-regional therapy. Fifty-three patients (26 DEB-TACE and 27 b-DEB-TACE) were analyzed in the TACE group. Contrast, signal-to-noise ratio, and contrast-to-noise ratio were all significantly higher in b-DEB-TACE subgroup than DEB-TACE (182.33 HU [CI95% 160.3–273.5] vs. 124 HU [CI95% 80.6–163.6]; 8.3 [CI95% 5.7–10.1] vs. 4.5 [CI95% 3.7–6.0]; 6.9 [CI95% 4.3–7.8] vs. 3.1 [CI95% 2.2–5.0] p.05). Thirty-one patients (24 SIRT and 7 b-SIRT) were analyzed in the SIRT group. 2D dosimetry profile evaluation showed an activity intensity peak significantly higher in the b-SIRT than in the SIRT subgroup (987.5 ± 393.8 vs. 567.7 ± 302.2, p = 0.005). Regarding 3D dose analysis, the mean dose administered to the treated lesions was significantly higher in the b-SIRT than in the SIRT group (151.6 Gy ± 53.2 vs. 100.1 Gy ± 43.4, p = 0.01). In histological explanted liver analysis, there was a trend for higher intra-tumoral localization of embolic microspheres for b-DEB-TACE in comparison with DEBTACE. Conclusions Due to the use of three different methods, the results of this study demonstrate in vivo, a better embolization profile of oncological intra-arterial interventions performed with balloon micro-catheter regardless of the embolic agent employed.| File | Dimensione | Formato | |
|---|---|---|---|
|
Lucatelli_In vivo comparison_2022.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
976.39 kB
Formato
Adobe PDF
|
976.39 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


